Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Austin

Showing results (361-370 of 786) with videos related to

Pageof 79
Sort By:
Plos One|December 3, 2015
Regional Heterogeneity of Cerebral Microvessels and Brain Susceptibility to Oxidative StressSusan A Austin, Anantha Vijay R Santhanam, Livius V d'Uscio, et al.
Journal of Registry Management|June 1, 2023
Identifying Factors Associated with Loss to Follow-up Among Patients Reported to the New York State Cancer RegistryBaozhen Qiao, April A Austin, Maria J Schymura, et al.
Molecular Pharmacology|June 27, 2020
Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent ComplexesRebecca L Swan, Luke L K Poh, Ian G Cowell, et al.
Nucleic Acids Research|March 22, 2006
mAMSA resistant human topoisomerase IIbeta mutation G465D has reduced ATP hydrolysis activityKathryn L Gilroy, Chrysoula Leontiou, Kay Padget, et al.
Letters in Applied Microbiology|January 1, 1999
Isolation of Aeromonas salmonicida in association with purple-pigmented bacteria in sediment from a Scottish lochD A Austin, P A Robertson, D K Wallace, et al.
Molecular Pharmacology|October 22, 2005
Mutation P732L in human DNA topoisomerase IIbeta abolishes DNA cleavage in the presence of calcium and confers drug resistanceChrysoula Leontiou, Jeremy H Lakey, Robert Lightowlers, et al.
Biochemical Society Transactions|February 5, 1998
Site-directed mutagenesis of human DNA topoisomerase II betaK L Marsh, E L Meczes, R Thorn, et al.
Molecular Pharmaceutics|December 2, 2024
The Future of Pharmaceutics: Showcasing Emerging Leaders in Drug DeliveryChun-Wan Yen, Patrick O'Dwyer, Weijun Wei, et al.
Therapeutic Delivery|July 28, 2012
Size matters: gold nanoparticles in targeted cancer drug deliveryErik C Dreaden, Lauren A Austin, Megan A Mackey, et al.
Personal Relationships|August 12, 2022
Romantic relationship distress, gender, socioeconomic status, and inflammation: A preregistered reportLisa M Jaremka, Heidi S Kane, Naoyuki Sunami, et al.
Pageof 79

Showing results (361-370 of 786) with videos related to

Sort By:
Pageof 79
Plos One|December 3, 2015
Regional Heterogeneity of Cerebral Microvessels and Brain Susceptibility to Oxidative StressSusan A Austin, Anantha Vijay R Santhanam, Livius V d'Uscio, et al.
Journal of Registry Management|June 1, 2023
Identifying Factors Associated with Loss to Follow-up Among Patients Reported to the New York State Cancer RegistryBaozhen Qiao, April A Austin, Maria J Schymura, et al.
Molecular Pharmacology|June 27, 2020
Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent ComplexesRebecca L Swan, Luke L K Poh, Ian G Cowell, et al.
Nucleic Acids Research|March 22, 2006
mAMSA resistant human topoisomerase IIbeta mutation G465D has reduced ATP hydrolysis activityKathryn L Gilroy, Chrysoula Leontiou, Kay Padget, et al.
Letters in Applied Microbiology|January 1, 1999
Isolation of Aeromonas salmonicida in association with purple-pigmented bacteria in sediment from a Scottish lochD A Austin, P A Robertson, D K Wallace, et al.
Molecular Pharmacology|October 22, 2005
Mutation P732L in human DNA topoisomerase IIbeta abolishes DNA cleavage in the presence of calcium and confers drug resistanceChrysoula Leontiou, Jeremy H Lakey, Robert Lightowlers, et al.
Biochemical Society Transactions|February 5, 1998
Site-directed mutagenesis of human DNA topoisomerase II betaK L Marsh, E L Meczes, R Thorn, et al.
Molecular Pharmaceutics|December 2, 2024
The Future of Pharmaceutics: Showcasing Emerging Leaders in Drug DeliveryChun-Wan Yen, Patrick O'Dwyer, Weijun Wei, et al.
Therapeutic Delivery|July 28, 2012
Size matters: gold nanoparticles in targeted cancer drug deliveryErik C Dreaden, Lauren A Austin, Megan A Mackey, et al.
Personal Relationships|August 12, 2022
Romantic relationship distress, gender, socioeconomic status, and inflammation: A preregistered reportLisa M Jaremka, Heidi S Kane, Naoyuki Sunami, et al.
Pageof 79